Hoth Therapeutics Inc (NASDAQ: HOTH) kicked off on Tuesday, down -17.99% from the previous trading day, before settling in for the closing price of $1.89. Over the past 52 weeks, HOTH has traded in a range of $0.58-$3.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 44.78%. With a float of $6.84 million, this company’s outstanding shares have now reached $6.90 million.
The extent of productivity of a business whose workforce counts for 6 workers is very important to gauge. In terms of profitability, gross margin is 50.0%, operating margin of -12647.51%, and the pretax margin is -12609.72%.
Hoth Therapeutics Inc (HOTH) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Hoth Therapeutics Inc is 0.93%, while institutional ownership is 5.31%. The most recent insider transaction that took place on Aug 16 ’24, was worth 16,750. In this transaction CEO and President of this company bought 25,000 shares at a rate of $0.67, taking the stock ownership to the 58,131 shares.
Hoth Therapeutics Inc (HOTH) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.78% per share during the next fiscal year.
Hoth Therapeutics Inc (NASDAQ: HOTH) Trading Performance Indicators
Take a look at Hoth Therapeutics Inc’s (HOTH) current performance indicators. Last quarter, stock had a quick ratio of 10.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.40, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Hoth Therapeutics Inc (HOTH)
The latest stats from [Hoth Therapeutics Inc, HOTH] show that its last 5-days average volume of 99.58 million was superior to 62.29 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 34.38%. Additionally, its Average True Range was 0.38.
During the past 100 days, Hoth Therapeutics Inc’s (HOTH) raw stochastic average was set at 28.56%, which indicates a significant increase from 27.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 443.38% in the past 14 days, which was higher than the 202.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9373, while its 200-day Moving Average is $0.9668. Now, the first resistance to watch is $1.7867. This is followed by the second major resistance level at $2.0233. The third major resistance level sits at $2.1467. If the price goes on to break the first support level at $1.4267, it is likely to go to the next support level at $1.3033. The third support level lies at $1.0667 if the price breaches the second support level.
Hoth Therapeutics Inc (NASDAQ: HOTH) Key Stats
The company with the Market Capitalisation of 10.70 million has total of 6,904K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -7,850 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -2,130 K.
